Skip to content

Treatment failure and drug resistance not associated with rapid death or illness in Côte d’Ivoire study

Three-quarters of people with HIV report poor mental or physical health

Bringing together opposites: how dialogue groups are helping to reduce HIV risk behaviour in Africa and Miami

Cancer: further evidence that long-term immune suppression will boost risk for people with HIV

Darunavir superior to lopinavir in 48-week study in treatment-experienced patients

Indian HIV estimate cut to 2.5 million people

TMC-125 and darunavir show strong effect in highly treatment-experienced, even without T-20

Thai programme demonstrates HIV services can be successfully delivered in prison

Brazil: Kaletra price cut agreed as generic efavirenz arrives